Immuno Oncology Therapy Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032

  • Report ID: ME_0078615
  • Format: Electronic (PDF)
  • Publish Type:
  • Number of Pages: 250
Home Healthcare immuno oncology therapy market....
  • Single User $3500
  • Multi User $4500
  • Enterprise User $5500

Market Snapshot

CAGR:8.28
2023
2032

Source: Market Expertz

RND-Favicon
Study Period 2019-2032
Base Year 2023
Forcast Year 2023-2032
CAGR 8.28
Healthcare-companies
Healthcare-Snapshot

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf
Download Sample Pdf

Report Overview

Summary

Cancer immunotherapy (sometimes called immuno-oncology) is the use of the immune system to treat cancer.
The global Immuno-oncology Therapy market was xx million US$ in 2018 and is expected to xx million US$ by the end of 2026, growing at a CAGR of xx% between 2019 and 2026.

This report studies the Immuno-oncology Therapy market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2026; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Immuno-oncology Therapy in these regions, from 2014 to 2026, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda 
By the product type, the market is primarily split into
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Others
By the end users/application, this report covers the following segments
Hospitals
Ambulatory Surgical Center
Others

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives of this report are:
To study and analyze the global Immuno-oncology Therapy market size (value & volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2026.
To understand the structure of Immuno-oncology Therapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Immuno-oncology Therapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Immuno-oncology Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Immuno-oncology Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Immuno-oncology Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026

This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Immuno-oncology Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Immuno-oncology Therapy market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.

Table of Contents

1 Immuno-oncology Therapy Market Overview
1.1 Immuno-oncology Therapy Product Overview
1.2 Immuno-oncology Therapy Market Segment by Type
1.2.1 Monoclonal Antibodies
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Immune System Modulators
1.2.4 Cancer Vaccines
1.2.5 Others
1.3 Global Immuno-oncology Therapy Market Size by Type
1.3.1 Global Immuno-oncology Therapy Sales and Growth by Type
1.3.2 Global Immuno-oncology Therapy Sales and Market Share by Type (2014-2019)
1.3.3 Global Immuno-oncology Therapy Revenue and Market Share by Type (2014-2019)
1.3.4 Global Immuno-oncology Therapy Price by Type (2014-2019)

2 Global Immuno-oncology Therapy Market Competition by Company
2.1 Global Immuno-oncology Therapy Sales and Market Share by Company (2014-2019)
2.2 Global Immuno-oncology Therapy Revenue and Share by Company (2014-2019)
2.3 Global Immuno-oncology Therapy Price by Company (2014-2019)
2.4 Global Top Players Immuno-oncology Therapy Manufacturing Base Distribution, Sales Area, Product Types
2.5 Immuno-oncology Therapy Market Competitive Situation and Trends
2.5.1 Immuno-oncology Therapy Market Concentration Rate
2.5.2 Global Immuno-oncology Therapy Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion

3 Immuno-oncology Therapy Company Profiles and Sales Data
3.1 Amgen
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Immuno-oncology Therapy Product Category, Application and Specification
3.1.3 Amgen Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 AstraZeneca
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Immuno-oncology Therapy Product Category, Application and Specification
3.2.3 AstraZeneca Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Bristol-Myers Squibb
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Immuno-oncology Therapy Product Category, Application and Specification
3.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Eli-Lilly
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Immuno-oncology Therapy Product Category, Application and Specification
3.4.3 Eli-Lilly Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Roche
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Immuno-oncology Therapy Product Category, Application and Specification
3.5.3 Roche Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 GlaxoSmithKline
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Immuno-oncology Therapy Product Category, Application and Specification
3.6.3 GlaxoSmithKline Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Janssen Biotech
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Immuno-oncology Therapy Product Category, Application and Specification
3.7.3 Janssen Biotech Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Merck
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Immuno-oncology Therapy Product Category, Application and Specification
3.8.3 Merck Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Novartis
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Immuno-oncology Therapy Product Category, Application and Specification
3.9.3 Novartis Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 Pfizer
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Immuno-oncology Therapy Product Category, Application and Specification
3.10.3 Pfizer Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
3.11 Sanofi
3.12 Spectrum Pharmaceuticals
3.13 Takeda 

4 Immuno-oncology Therapy Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Immuno-oncology Therapy Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Immuno-oncology Therapy Sales and Revenue by Regions
4.2.1 Global Immuno-oncology Therapy Sales and Market Share by Regions (2014-2019)
4.2.2 Global Immuno-oncology Therapy Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries

5 Immuno-oncology Therapy Application/End Users
5.1 Immuno-oncology Therapy Segment by Application
5.1.1 Hospitals
5.1.2 Ambulatory Surgical Center
5.1.3 Others
5.2 Global Immuno-oncology Therapy Product Segment by Application
5.2.1 Global Immuno-oncology Therapy Sales by Application
5.2.2 Global Immuno-oncology Therapy Sales and Market Share by Application (2014-2019)

6 Global Immuno-oncology Therapy Market Forecast
6.1 Global Immuno-oncology Therapy Sales, Revenue Forecast (2019-2025)
6.1.1 Global Immuno-oncology Therapy Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Immuno-oncology Therapy Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Immuno-oncology Therapy Forecast by Regions
6.2.1 North America Immuno-oncology Therapy Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Immuno-oncology Therapy Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Immuno-oncology Therapy Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Immuno-oncology Therapy Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Immuno-oncology Therapy Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Immuno-oncology Therapy Forecast by Type
6.3.1 Global Immuno-oncology Therapy Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Monoclonal Antibodies Gowth Forecast
6.3.3 Immune Checkpoint Inhibitors Gowth Forecast
6.4 Immuno-oncology Therapy Forecast by Application
6.4.1 Global Immuno-oncology Therapy Sales Forecast by Application (2019-2025)
6.4.2 Global Immuno-oncology Therapy Forecast in Hospitals
6.4.3 Global Immuno-oncology Therapy Forecast in Ambulatory Surgical Center

7 Immuno-oncology Therapy Upstream Raw Materials
7.1 Immuno-oncology Therapy Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Immuno-oncology Therapy Industrial Chain Analysis

8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers

9 Research Findings and Conclusion

Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer


List of Tables and Figures

Figure Immuno-oncology Therapy Product Picture
Figure Global Immuno-oncology Therapy Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Immuno-oncology Therapy Sales (K Units) Status and Outlook (2014-2025)
Figure Product Picture of Monoclonal Antibodies
Table Major Players of Monoclonal Antibodies
Figure Global Monoclonal Antibodies Sales (K Units) and Growth Rate (%)(2014-2018)
Figure Product Picture of Immune Checkpoint Inhibitors
Table Major Players of Immune Checkpoint Inhibitors
Figure Global Immune Checkpoint Inhibitors Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Immune System Modulators
Table Major Players of Immune System Modulators
Figure Global Immune System Modulators Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Cancer Vaccines
Table Major Players of Cancer Vaccines
Figure Global Cancer Vaccines Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Units) and Growth Rate (%)(2014-2019)
Table Global Immuno-oncology Therapy Sales (K Units) and Growth Rate (%) Comparison by Type
Table Global Immuno-oncology Therapy Sales (K Units) by Type (2014-2019)
Table Global Immuno-oncology Therapy Sales Share (%) by Type (2014-2019)
Figure Global Immuno-oncology Therapy Sales Market Share (%) by Type (2014-2019)
Figure Global Immuno-oncology Therapy Sales Market Share (%) by Type in 2018
Table Global Immuno-oncology Therapy Revenue (Million USD) by Type (2014-2019)
Table Global Immuno-oncology Therapy Revenue Share (%) by Type (2014-2019)
Figure Global Immuno-oncology Therapy Revenue Share (%) by Type (2014-2019)
Figure 2018 Global Immuno-oncology Therapy Revenue Market Share (%) by Type
Table Global Immuno-oncology Therapy Price (USD/Unit) by Type (2014-2019)
Table Global Immuno-oncology Therapy Sales (K Units) by Company (2014-2019)
Table Global Immuno-oncology Therapy Sales Share (%) by Company (2014-2019)
Figure Global Immuno-oncology Therapy Sales Share (%) by Company in 2018
Table Global Immuno-oncology Therapy Revenue (Million USD) by Company (2014-2019)
Table Global Immuno-oncology Therapy Revenue Share (%) by Company (2014-2019)
Figure Global Immuno-oncology Therapy Revenue Share (%) by Company in 2018
Table Global Market Immuno-oncology Therapy Average Price (USD/Unit) by Company (2014-2019)
Table Global Immuno-oncology Therapy Top Players Manufacturing Base Distribution and Sales Area
Table Global Immuno-oncology Therapy Top Players Product Category
Figure Global Immuno-oncology Therapy Market Share (%) of Top 5 Players
Figure Global Immuno-oncology Therapy Market Share (%) of Top 10 Players
Table Amgen Basic Information List
Table Amgen Immuno-oncology Therapy Product Category, Application and Specification
Table Amgen Immuno-oncology Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Amgen Immuno-oncology Therapy Sales Growth Rate (2014-2019)
Figure Amgen Immuno-oncology Therapy Sales Global Market Share (%)(2014-2019)
Table AstraZeneca Basic Information List
Figure AstraZeneca Immuno-oncology Therapy Product Category, Application and Specification
Table AstraZeneca Immuno-oncology Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure AstraZeneca Immuno-oncology Therapy Sales Growth Rate (2014-2019)
Figure AstraZeneca Immuno-oncology Therapy Sales Global Market Share (%)(2014-2019)
Table Bristol-Myers Squibb Basic Information List
Figure Bristol-Myers Squibb Immuno-oncology Therapy Product Category, Application and Specification
Table Bristol-Myers Squibb Immuno-oncology Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Bristol-Myers Squibb Immuno-oncology Therapy Sales Growth Rate (2014-2019)
Figure Bristol-Myers Squibb Immuno-oncology Therapy Sales Global Market Share (%)(2014-2019)
Table Eli-Lilly Basic Information List
Figure Eli-Lilly Immuno-oncology Therapy Product Category, Application and Specification
Table Eli-Lilly Immuno-oncology Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Eli-Lilly Immuno-oncology Therapy Sales Growth Rate (2014-2019)
Figure Eli-Lilly Immuno-oncology Therapy Sales Global Market Share (%)(2014-2019)
Table Roche Basic Information List
Figure Roche Immuno-oncology Therapy Product Category, Application and Specification
Table Roche Immuno-oncology Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Roche Immuno-oncology Therapy Sales Growth Rate (2014-2019)
Figure Roche Immuno-oncology Therapy Sales Global Market Share (%)(2014-2019)
Table GlaxoSmithKline Basic Information List
Figure GlaxoSmithKline Immuno-oncology Therapy Product Category, Application and Specification
Table GlaxoSmithKline Immuno-oncology Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure GlaxoSmithKline Immuno-oncology Therapy Sales Growth Rate (2014-2019)
Figure GlaxoSmithKline Immuno-oncology Therapy Sales Global Market Share (%)(2014-2019)
Table Janssen Biotech Basic Information List
Figure Janssen Biotech Immuno-oncology Therapy Product Category, Application and Specification
Table Janssen Biotech Immuno-oncology Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Janssen Biotech Immuno-oncology Therapy Sales Growth Rate (2014-2019)
Figure Janssen Biotech Immuno-oncology Therapy Sales Global Market Share (%)(2014-2019)
Table Merck Basic Information List
Figure Merck Immuno-oncology Therapy Product Category, Application and Specification
Table Merck Immuno-oncology Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Merck Immuno-oncology Therapy Sales Growth Rate (2014-2019)
Figure Merck Immuno-oncology Therapy Sales Global Market Share (%)(2014-2019)
Table Novartis Basic Information List
Figure Novartis Immuno-oncology Therapy Product Category, Application and Specification
Table Novartis Immuno-oncology Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Novartis Immuno-oncology Therapy Sales Growth Rate (2014-2019)
Figure Novartis Immuno-oncology Therapy Sales Global Market Share (%)(2014-2019)
Table Pfizer Basic Information List
Figure Pfizer Immuno-oncology Therapy Product Category, Application and Specification
Table Pfizer Immuno-oncology Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Pfizer Immuno-oncology Therapy Sales Growth Rate (2014-2019)
Figure Pfizer Immuno-oncology Therapy Sales Global Market Share (%)(2014-2019)
Table Sanofi Basic Information List
Table Spectrum Pharmaceuticals Basic Information List
Table Takeda  Basic Information List
Table Global Immuno-oncology Therapy Market Size Comparison by Regions (2014-2025)
Figure North America Immuno-oncology Therapy Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific Immuno-oncology Therapy Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe Immuno-oncology Therapy Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America Immuno-oncology Therapy Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa Immuno-oncology Therapy Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global Immuno-oncology Therapy Sales (K Units) by Regions (2014-2019)
Table Global Immuno-oncology Therapy Sales Market Share (%) by Regions (2014-2019)
Figure Global Immuno-oncology Therapy Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global Immuno-oncology Therapy Sales Market Share (%) by Regions
Table Global Immuno-oncology Therapy Revenue (Million USD) by Regions (2014-2019)
Table Global Immuno-oncology Therapy Revenue Market Share (%) by Regions (2014-2019)
Figure Global Immuno-oncology Therapy Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global Immuno-oncology Therapy Revenue Market Share (%) by Regions
Table Global Immuno-oncology Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North America Immuno-oncology Therapy Sales Growth Rate
Table North America Immuno-oncology Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure United States Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure United States Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Canada Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure Canada Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Mexico Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure Mexico Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Europe Immuno-oncology Therapy Sales Growth Rate
Table Europe Immuno-oncology Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Germany Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure Germany Immuno-oncology Therapy Revenue (Million USD) (2014-2019)
Figure UK Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure UK Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure France Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure France Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Italy Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure Italy Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Russia Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure Russia Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Turkey Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure Turkey Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Immuno-oncology Therapy Sales Growth Rate
Table Asia-Pacific Immuno-oncology Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure China Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure China Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Japan Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure Japan Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Korea Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure Korea Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Southeast Asia Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure Southeast Asia Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Indonesia Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure Indonesia Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Thailand Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure Thailand Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Malaysia Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure Malaysia Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Philippines Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure Philippines Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Vietnam Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure Vietnam Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure India Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure India Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Australia Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure Australia Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure South America Immuno-oncology Therapy Sales Growth Rate
Table South America Immuno-oncology Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Brazil Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure Brazil Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Middle East and Africa Immuno-oncology Therapy Sales Growth Rate
Table Middle East and Africa Immuno-oncology Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North Africa Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure North Africa Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure GCC Countries Immuno-oncology Therapy Sales (K Units)(2014-2019)
Figure GCC Countries Immuno-oncology Therapy Revenue (Million USD)(2014-2019)
Figure Hospitals Examples
Figure Ambulatory Surgical Center Examples
Figure Others Examples
Table Global Immuno-oncology Therapy Sales (K Units) Comparison by Application (2014-2025)
Table Global Immuno-oncology Therapy Sales (K Units) by Application (2014-2019)
Table Global Immuno-oncology Therapy Sales Share (%) by Application (2014-2019)
Figure Global Immuno-oncology Therapy Sales Market Share (%) by Application (2014-2019)
Figure Global Immuno-oncology Therapy Sales Market Share (%) by Application in 2018
Figure Global Immuno-oncology Therapy Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Global Immuno-oncology Therapy Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global Immuno-oncology Therapy Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Immuno-oncology Therapy Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America Immuno-oncology Therapy Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North America Immuno-oncology Therapy Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe Immuno-oncology Therapy Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Europe Immuno-oncology Therapy Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Immuno-oncology Therapy Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Immuno-oncology Therapy Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China Immuno-oncology Therapy Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure China Immuno-oncology Therapy Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan Immuno-oncology Therapy Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Japan Immuno-oncology Therapy Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea Immuno-oncology Therapy Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Korea Immuno-oncology Therapy Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Immuno-oncology Therapy Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Immuno-oncology Therapy Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India Immuno-oncology Therapy Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure India Immuno-oncology Therapy Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia Immuno-oncology Therapy Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Australia Immuno-oncology Therapy Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America Immuno-oncology Therapy Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure South America Immuno-oncology Therapy Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Immuno-oncology Therapy Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Immuno-oncology Therapy Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Immuno-oncology Therapy Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Immuno-oncology Therapy Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Immuno-oncology Therapy Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Immuno-oncology Therapy Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global Immuno-oncology Therapy Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Immuno-oncology Therapy Sales Market Share (%) Forecast by Type (2019-2025)
Table Global Immuno-oncology Therapy Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Immuno-oncology Therapy Revenue Market Share (%) Forecast by Type (2019-2025)
Figure Monoclonal Antibodies Sales Growth Forecast
Figure Immune Checkpoint Inhibitors Sales Growth Forecast
Table Global Immuno-oncology Therapy Sales (K Units) Forecast by Application (2019-2025)
Figure Global Immuno-oncology Therapy Sales Forecast by Application (2019-2025)
Figure Global Immuno-oncology Therapy Sales (K Units) Forecast in Hospitals
Figure Global Immuno-oncology Therapy Sales (K Units) Forecast in Ambulatory Surgical Center
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Immuno-oncology Therapy Manufacturing Cost Structure
Figure Immuno-oncology Therapy Industrial Chain Analysis
Table Distributors List
Table Immuno-oncology Therapy Downstream Customers

RESEARCH METHODOLOGY

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now let’s take a closer look at the research methods here.

Secondary Research Model

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Personalized Business Report Tailored to Your Requirements

  • Our expert analysts collaborate directly with you to comprehend your specific needs.
  • Get data on regions, segments, competitors, and vendors of your choice.
  • Information is presented in alignment with your exact preferences and formatting.
Free Sample Report

"Find new revenue generation opportunities"